Ocugen (OCGN) Other Non-Current Assets (2014 - 2026)
Ocugen (OCGN) posted Other Non-Current Assets of $318000.0 for Q1 2026, up 0.63% on a QoQ basis from $316000.0 in Q4 2025, and up 2.91% year-over-year from $309000.0 in Q1 2025.
Ocugen (OCGN) Other Non-Current Assets (2014 - 2026) Analysis & Trends
Ocugen's Other Non-Current Assets history runs 13 years deep, the most recent figure standing at $318000.0 for Q1 2026.
- Quarterly Other Non-Current Assets rose 2.91% year-over-year to $318000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $318000.0 (up 2.91% YoY) and the FY2025 annual result came in at $316000.0, up 2.93% from the prior year.
- Other Non-Current Assets was $318000.0 for Q1 2026 at Ocugen, up from $316000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $5.0 million in Q2 2025 and bottomed at $151000.0 in Q1 2022.
- A 5-year average of $1.9 million and a median of $316000.0 in 2025 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 2791.39% — and 2024, when it plunged 92.84%.
- Ocugen's Other Non-Current Assets stood at $4.1 million in 2022, then increased by 4.87% to $4.3 million in 2023, then plunged by 92.84% to $307000.0 in 2024, then climbed by 2.93% to $316000.0 in 2025, then increased by 0.63% to $318000.0 in 2026.
- Business Quant data shows OCGN's Other Non-Current Assets at $318000.0 in Q1 2026, $316000.0 in Q4 2025, and $314000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - | 318,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 318,000.00 |
| Dec 31, 2025 | 316,000.00 |
| Sep 30, 2025 | 314,000.00 |
| Jun 30, 2025 | 4.95 Mn |
| Mar 31, 2025 | 309,000.00 |
| Dec 31, 2024 | 307,000.00 |
| Sep 30, 2024 | 305,000.00 |
| Jun 30, 2024 | 302,000.00 |
| Dec 31, 2023 | 4.29 Mn |
| Dec 31, 2022 | 4.09 Mn |
| Sep 30, 2022 | 4.23 Mn |
| Jun 30, 2022 | 4.37 Mn |
| Mar 31, 2022 | 151,000.00 |
| Dec 31, 2021 | 151,000.00 |
| Sep 30, 2021 | 151,000.00 |
| Jun 30, 2021 | 151,000.00 |
| Mar 31, 2021 | 151,000.00 |
| Dec 31, 2020 | 714,000.00 |
| Sep 30, 2020 | 151,000.00 |
| Jun 30, 2020 | 151,000.00 |